高度近视白内障行超声乳化联合折叠式IOL植入术的临床观察

Clinical observation of phacoemulsification combined foldable intraocular lens implantation on high myopia with cataract

目的:观察高度近视并发白内障行超声乳化联合折叠式人工晶状体(IOL)植入术的临床疗效。方法:对41例62眼高度近视并白内障患者行超声乳化吸除联合推注式折叠IOL植入术,观察术中术后并发症及术后视力,术后随访1～6(平均3)mo。结果:术中后囊膜破裂3眼;术后1d裸眼视力<0.1共7眼(11%),0.1≤视力<0.5共42眼(68%),视力≥0.5共13眼(21%);术后3mo裸眼视力<0.1共4眼(6%),0.1≤视力<0.5共40眼(65%),视力≥0.5共18眼(29%)。3mo后最佳矫正视力<0.1共2眼(3%),0.1≤视力<0.5共36眼(58%),最佳矫正视力≥0.5共24眼(39%)。随访中3眼(5%)晶状体后囊膜混浊,未出现视网膜、脉络膜脱离和黄斑水肿等其他并发症。结论:高度近视并白内障行超声乳化联合折叠式人工晶状体植入术,安全可靠,手术并发症少,术后视力恢复快。

AIM： To evaluate the clinical effects of phacoemulsification combined the foldable intraocular lens implantation on patients with myopia and cataract. METHODS：This study evaluated 62 eyes of 41 patients with myopia and cataract who received phacoemulsification combined the foldable intraocular lens implantation, and the intraoperative and postoperative complications, postoperative visual acuity were observed. The follow-up time was from 1 month to 6 months, average 3 months.RESULTS： Posterior capsule rupture postoperatively occurred in 3 eyes and no other intraoperative complications. The first day after surgery, the uncorrected visual acuity of 0.1 were in 7 eyes （11%）, 0.1≤visual acuity0.5 in 42 eyes （68%）, visual acuity≥0.5 in 13 eyes （21%）; follow-up 3 months, the uncorrected visual acuity 0.1 were in 4 eyes（6%）, 0.1≤ visual acuity0.5 in 40 eyes（65%）, visual acuity≥0.5 in 18 eyes （29%）.The best-corrected visual acuity 0.1 were in 2 eyes （3%）, 0.1≤visual acuity0.5 in 36 eyes （58%）, visual acuity≥0.5 in 24 eyes （39%）, in the follow-up posterior lens capsule opacity was in 3 eyes （5%）, without retinal detachment, choroidal detachment and macular edema.CONCLUSION： It is safe and effective for high myopia with cataract to implant a foldable intraocular lens after phacoemulsification.